Subscribe!
Poster Presentation: piggyBac® Transposase and Cas-CLOVER™ Targeted Nuclease Enable Rapid Discovery of Novel Hot Spots in HEK293 Suspension Cells
Poster Presentation: piggyBac® Transposase and Cas-CLOVER™ Targeted Nuclease Enable Rapid ...
Demeetra Cas-CLOVER Research Selected as a MDPI Journal Editor’s Choice Article
Demeetra Cas-CLOVER Research Selected as a MDPI Journal Editor's Choice ...
GEN Webinar: Cas-CLOVER: The Clean Alternative to CRISPR-Cas9
In this 2020 introductory webinar "Cas-CLOVER: A Clean Alternative to ...
Demeetra’s Guide to CRISPR and Gene Editing Licensing
Demeetra's Guide to CRISPR and Gene Editing Licensing Blog Agriculture ...
Q&A Podcast: Cas-CLOVER Capable of Meeting Crop Improvement Challenges
Q&A Podcast: Cas-CLOVER Capable of Meeting Crop Improvement Challenges Blog ...
Q&A Podcast: The Possibilities of Cas-CLOVER and piggyBac
Q&A Podcast: The Possibilities of Cas-CLOVER and piggyBac Blog Synthetic ...
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Dublin, Ireland and Kentucky, USA, September 12: ERS Genomics Limited ...
Guide RNA Design For Cas-CLOVER
Dimerization of our Cas-CLOVER gene editing technology requires the design ...
The Ultimate Guide to Gene Editing in Wheat
The Complicated History of Wheat Wheat has had a complicated ...
Protein Engineered Cas-CLOVER Yields 99% Gene Editing Efficiency and Ultra-Low Toxicity
At the 2022 Bioprocessing Summit, Demeetra’s Corey Brizzee presented Cas-CLOVER’s ...